Sanrith Descartes
You have insufficient privileges to reply here.
- 46,738
- 131,318
Investing General Discussion
- Thread starter Furious
- Start date
- 11,622
- 63,766
Shonuff
forgive me, but I don't understand your thinking on these plays. You're following Cramer, who's giving out price targets for where to buy and where he thinks they're going to go. That he's giving those price targets for where they're going is the REASON to buy them, IMO. If you didn't agree with his thinking about where they were heading, you wouldn't listen to his picks, right?So when you have say WYNN, which he is predicting will go to 140 on that list you posted, why would you consider bailing when it's not even at 100? I could see something closer to 140, but where we are now seems awfully low.
Don't get me wrong, I'm not criticizing you and I like what you're posting I'm just trying to get where you're coming from.
Shonuff
Mr. Poopybutthole
- 5,538
- 791
I don't know what you are talking about. I follow Cramer, I don't go with all of his picks (sometimes to my detriment, sometimes I win). WYNN, I'm not bailing on, I'm adding to, and it will be long term.
So when you have say WYNN, which he is predicting will go to 140 on that list you posted, why would you consider bailing when it's not even at 100? I could see something closer to 140, but where we are now seems awfully low.
Don't get me wrong, I'm not criticizing you and I like what you're posting I'm just trying to get where you're coming from.
MSGE was not one recommended by Cramer, my post there explains my line of thinking. Nobody wanted to touch it last week. I bought every travel company that was at the epicenter that had a decent balance sheet. EXPE, LYV, NCLH, ALK, LVS, LYV, MA, RCL, TRIP, UAL. WEN and JETS. None of those were Cramer picks until last night, I bought those last week (with the exception of the JETS ETF that I bought the second the vaccine approval came across the CNBC newsfeed). I think I've made about 5k on them in two days so far just sitting on them.
Like I said, I'm not selling them unless they get ahead of themselves. Like if they jump another 10% in the next day or so, at that point, I'd probably sell and start day trading them. Because if they get so far ahead of themselves, they start to retrace. You should worry a little bit if your stock is increasing 10% a day for multiple days. They start to take profits. WYNN, MA and BA are long term holds. The rest are trades. I don't want to be in them long enough for people to start focusing on the balance sheet issues. Some of them have diluted so many shares and taken on so much debt. Its better for me to trade around the story, but not be here when the earnings report comes out. Sometimes, the story is better than the reality.
Did I answer?
Last edited:
- 1
Shonuff
Mr. Poopybutthole
- 5,538
- 791
I don't know that we are that different.
Interesting, on the video Cramer just sent for actionalerts, he's pounding the table on MA and WYNN. Tomorrow is the members only call (don't miss it). But he's already stated that MA is the number one epicenter stock he'd rather be in (above all else). And he said he's going to tell us to double our position in WYNN. I certainly wish I bought more Nucor when he was pounding the table on it last week (order didn't fill).
- 1
- 11,622
- 63,766
Ya, I think I was misunderstanding some of your earlier posts a bit. I'm a n00b involving a lot of the finer points of all this so I'm just trying to figure out your strategy.
Appreciate it
Shonuff
Mr. Poopybutthole
- 5,538
- 791
I added more text to my post tell you my line of reasoning and make sure I am being clear.Ya, I think I was misunderstanding some of your earlier posts a bit. I'm a n00b involving a lot of the finer points of all this so I'm just trying to figure out your strategy.
Appreciate it
- 1
Sanrith Descartes
You have insufficient privileges to reply here.
- 46,738
- 131,318
Speaking of MA, its really interesting to me watching the two of them side-by-side. They are basically the same product.
Shonuff
Mr. Poopybutthole
- 5,538
- 791
Algorithms move everything at the same time nowadays. When I used to day trade multiple stocks, I had to stop doing the same industry. Because if something went wrong, you get stopped out twice at the same time. Literally in the same minute. For awhile there, Zoom and Tesla used to share the exact day chart. So I stopped trading both, and just traded the one.
Shonuff
Mr. Poopybutthole
- 5,538
- 791
Not sure I want to double my position in WYNN. Cramer said the Chinese government has lowered the covid window for WYNN because they believe its under control, and they want to send a message. They are anti-tech, but not anti-gambling. Still on the fence on this.
This is one that I started buying at 122. When Cramer is so vehement to double our position in it, I don't know what to do.
This is one that I started buying at 122. When Cramer is so vehement to double our position in it, I don't know what to do.
- 1
Kiroy
Marine Biologist
- 35,864
- 105,200
I was curious why cramer would be so crazy about ma but not the other card companies
Sanrith Descartes
You have insufficient privileges to reply here.
- 46,738
- 131,318
I tweeted to him about MA vs V but he didn't respond. I was curious as well. I am a big fan of the space (with V, MA and PYPL). I would also own SQ but fuck Jack Dorsey.
- 1
Sanrith Descartes
You have insufficient privileges to reply here.
- 46,738
- 131,318
Shonuff
Mr. Poopybutthole
- 5,538
- 791
For Kiroy . Pulled from Cramer's members only group on Mastercard.
"We are also jumping on the recent weakness in Mastercard and re-initiating a position. Here is a stock we sold back in April at around $395 per share in our Alert here, and we like this opportunity to buy back half the stock we sold at an 8% discount as of the current price.
Despite posting a strong second quarter earnings result last Thursday, the stock has been battered over the past two days on concerns that Square's (SQ) acquisition of a Buy Now, Pay Later fintech Afterpay (AFTPF) will disrupt the traditional credit card operators. We think these concerns will prove to be overblown and Mastercard has its own offering through its partnership with payment processor TSYS anyways.
We also believe the stock has been weak lately, and especially today, on concerns that the Delta variant and rising COVID-19 infections will slowdown the recovery in cross-border travel. The Delta variant is clearly one of the biggest variables in the market today and tough to handicap, but what we want to go back to is how optimistic Mastercard sounded on their earnings call about the recovery in cross-border. Remember, that earnings call took place on July 29th and not a whole lot has changed between now and then besides market sentiment.
Mastercard specifically cited strength between the United States and Latin America and noted an increase in travel within Europe too. Additionally, Mastercard noted how its industry reports have seen an increase in bookings for travel between the United States and in Europe. Mastercard pointed out how quarantine requirements for entry in Canada are starting to be relaxed too, representing another opportunity.
Mastercard has more exposure to international markets than Visa (V) , making it more of a risk to the downside if Delta is an ongoing problem to travel. But that also makes Mastercard the better investment today if you believe the global markets will inevitably get past COVID as we do.
The recovery in cross-border volumes is an important part of the Mastercard, but let's not also forget how the credit card network companies benefit from the global secular shift toward card based and electronic payments as well. We believe the trajectory in spending trends is positive right now as Mastercard called out on its recent call how "switched volumes continue to improve quarter-over-quarter, with strength across all products. Debit spend remains elevated, and we are seeing further recovery in credit, driven in part by the return of travel and increased discretionary spending."
"This recovery is led by consumer credit, but it's important to note that commercial credit is also improving and has now reached pre-pandemic levels as well. In terms of how people are spending, they are definitely getting out more as we're seeing improvement in card-present spending, particularly in the travel, retail and restaurant categories, while e-commerce continues to be strong."
We are starting relatively small in MA as we, of course, want to leave room to scale into the position over time. While we believe the stock has significant room for upside, we also recognize that concerns around the Delta variant and the potential for more travel restrictions could elongate the cross-border international travel recovery and keep the stock volatile. We view additional pullbacks as buying opportunities in what is a post-COVID story.
We are initiating the position with a $425 price target, which reflects roughly 40x 2022 consensus EPS estimates. That being said, we believe there is more room for upside here on earnings growth should the recovery prove to be faster than anticipated."
"We are also jumping on the recent weakness in Mastercard and re-initiating a position. Here is a stock we sold back in April at around $395 per share in our Alert here, and we like this opportunity to buy back half the stock we sold at an 8% discount as of the current price.
Despite posting a strong second quarter earnings result last Thursday, the stock has been battered over the past two days on concerns that Square's (SQ) acquisition of a Buy Now, Pay Later fintech Afterpay (AFTPF) will disrupt the traditional credit card operators. We think these concerns will prove to be overblown and Mastercard has its own offering through its partnership with payment processor TSYS anyways.
We also believe the stock has been weak lately, and especially today, on concerns that the Delta variant and rising COVID-19 infections will slowdown the recovery in cross-border travel. The Delta variant is clearly one of the biggest variables in the market today and tough to handicap, but what we want to go back to is how optimistic Mastercard sounded on their earnings call about the recovery in cross-border. Remember, that earnings call took place on July 29th and not a whole lot has changed between now and then besides market sentiment.
Mastercard specifically cited strength between the United States and Latin America and noted an increase in travel within Europe too. Additionally, Mastercard noted how its industry reports have seen an increase in bookings for travel between the United States and in Europe. Mastercard pointed out how quarantine requirements for entry in Canada are starting to be relaxed too, representing another opportunity.
Mastercard has more exposure to international markets than Visa (V) , making it more of a risk to the downside if Delta is an ongoing problem to travel. But that also makes Mastercard the better investment today if you believe the global markets will inevitably get past COVID as we do.
The recovery in cross-border volumes is an important part of the Mastercard, but let's not also forget how the credit card network companies benefit from the global secular shift toward card based and electronic payments as well. We believe the trajectory in spending trends is positive right now as Mastercard called out on its recent call how "switched volumes continue to improve quarter-over-quarter, with strength across all products. Debit spend remains elevated, and we are seeing further recovery in credit, driven in part by the return of travel and increased discretionary spending."
"This recovery is led by consumer credit, but it's important to note that commercial credit is also improving and has now reached pre-pandemic levels as well. In terms of how people are spending, they are definitely getting out more as we're seeing improvement in card-present spending, particularly in the travel, retail and restaurant categories, while e-commerce continues to be strong."
We are starting relatively small in MA as we, of course, want to leave room to scale into the position over time. While we believe the stock has significant room for upside, we also recognize that concerns around the Delta variant and the potential for more travel restrictions could elongate the cross-border international travel recovery and keep the stock volatile. We view additional pullbacks as buying opportunities in what is a post-COVID story.
We are initiating the position with a $425 price target, which reflects roughly 40x 2022 consensus EPS estimates. That being said, we believe there is more room for upside here on earnings growth should the recovery prove to be faster than anticipated."
Shonuff
Mr. Poopybutthole
- 5,538
- 791
Sanrith Descartes
You have insufficient privileges to reply here.
- 46,738
- 131,318
Shonuff
Mr. Poopybutthole
- 5,538
- 791
Cramer's already said that tomorrow he's going to say double it. Says MA and WYNN are golden right now.
Maybe I should wait until the short squeeze is over.
- 1
Shonuff
Mr. Poopybutthole
- 5,538
- 791
Pulled from action alerts:
"Mastercard has more exposure to international markets than Visa (V) , making it more of a risk to the downside if Delta is an ongoing problem to travel. But that also makes Mastercard the better investment today if you believe the global markets will inevitably get past COVID as we do."
From the video today, he says MA is going up $100 a share from here.
- 1